Activity Levels in Bone Marrow Transplant Patients
Launched by MICHAEL TOMASSON · Oct 2, 2019
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how activity levels affect patients who are undergoing a bone marrow transplant. Researchers want to understand if being active can influence how long patients stay in the hospital, their overall quality of life, and their hand grip strength after the transplant. This is important because it can help improve care and recovery for patients.
To participate in this study, you need to be someone who is scheduled to receive a bone marrow transplant. The study is open to individuals aged 65 to 74 and those aged 36 to 159 (which likely includes a wide range of adult ages). If you join the study, you will be monitored for your activity levels and how these relate to your recovery. This information could provide valuable insights that benefit future patients.
Gender
ALL
Eligibility criteria
- • Patients who will be receiving a bone marrow transplant are eligible for this study
About Michael Tomasson
Michael Tomasson is a distinguished clinical trial sponsor recognized for his commitment to advancing medical research and improving patient outcomes. With extensive expertise in oncology and hematology, he leads innovative clinical trials that explore novel therapeutic approaches and enhance treatment modalities. His collaborative efforts with leading academic institutions and pharmaceutical partners underscore a dedication to scientific rigor and ethical standards in clinical research. Through a patient-centric focus, Tomasson aims to translate promising discoveries into tangible benefits for patients, driving progress in the fight against complex diseases.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Iowa City, Iowa, United States
Patients applied
Trial Officials
Michael Tomasson, MD
Principal Investigator
University of Iowa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials